Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Letter
  • Published:

The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with β-blockade

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Brayden JE, Nelson MT . Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 1992; 256: 532–535.

    Article  CAS  Google Scholar 

  2. Knot HJ, Nelson MT . Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 1998; 508 (Part 1): 199–209.

    Article  CAS  Google Scholar 

  3. Brenner R, Perez GJ, Bonev AD, Eckman DM, Kosek JC, Wiler SW et al. Vasoregulation by the beta1 subunit of the calcium-activated potassium channel. Nature 2000; 407: 870–876.

    Article  CAS  Google Scholar 

  4. Fernandez-Fernandez JM, Tomas M, Vazquez E, Orio P, Latorre R, Senti M et al. Gain-of-function mutation in the KCNMB1 potassium channel subunit is associated with low prevalence of diastolic hypertension. J Clin Invest 2004; 113: 1032–1039.

    Article  CAS  Google Scholar 

  5. Senti M, Fernandez-Fernandez JM, Tomas M, Vazquez E, Elosua R, Marrugat J et al. Protective effect of the KCNMB1 E65K genetic polymorphism against diastolic hypertension in aging women and its relevance to cardiovascular risk. Circ Res 2005; 97: 1360–1365.

    Article  CAS  Google Scholar 

  6. Kokubo Y, Iwai N, Tago N, Inamoto N, Okayama A, Yamawaki H et al. Association analysis between hypertension and CYBA, CLCNKB, and KCNMB1 functional polymorphisms in the Japanese population—the Suita Study. Circ J 2005; 69: 138–142.

    Article  CAS  Google Scholar 

  7. Tobin MD, Sheehan NA, Scurrah KJ, Burton PR . Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 2005; 24: 2911–2935.

    Article  Google Scholar 

  8. Beitelshees AL, Gong Y, Wang D, Schork NJ, Cooper-Dehoff RM, Langaee TY et al. KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST). Pharmacogenet Genomics 2007; 17: 719–729.

    Article  CAS  Google Scholar 

  9. Skol AD, Scott LJ, Abecasis GR, Boehnke M . Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006; 38: 209–213.

    Article  CAS  Google Scholar 

  10. Amberg GC, Bonev AD, Rossow CF, Nelson MT, Santana LF . Modulation of the molecular composition of large conductance, Ca(2+) activated K(+) channels in vascular smooth muscle during hypertension. J Clin Invest 2003; 112: 717–724.

    Article  CAS  Google Scholar 

  11. Amberg GC, Santana LF . Downregulation of the BK channel beta1 subunit in genetic hypertension. Circ Res 2003; 93: 965–971.

    Article  CAS  Google Scholar 

  12. Liu G, Shi J, Yang L, Cao L, Park SM, Cui J et al. Assembly of a Ca2+-dependent BK channel signaling complex by binding to beta2 adrenergic receptor. EMBO J 2004; 23: 2196–2205.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This project is funded, in part, under a grant with the Pennsylvania Department of Health (SER) (contract no. ME-02-384). The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. This project was supported by the National Institutes of Health program project Grant no. HL077378 and training grant no. HL069770 (MEM). This work was supported by the National Heart, Lung and Blood Institute's Framingham Heart Study (contract no. N01-HC-25195) and Boston University School of Medicine.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G S Huggins.

Additional information

Disclosure/conflict of interest

None.

Supplementary Information accompanies the paper on the Journal of Human Hypertension website (http://www.nature.com/jhh)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kelley-Hedgepeth, A., Peter, I., Kip, K. et al. The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with β-blockade. J Hum Hypertens 22, 512–515 (2008). https://doi.org/10.1038/jhh.2008.23

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2008.23

This article is cited by

Search

Quick links